# Cenova Capital

> Cenova Capital is a VC fund in Xuhui backing Medical, Health Care and Therapeutics. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Xuhui, China
- Total investments: 9
- Last investment: Feb 2023
- Lead investor: 33%
- Last updated: Aug 2026

Cenova Capital is a VC fund in Xuhui focused on Medical and Health Care. Cenova Capital is one of the earliest healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sectors in China.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 33% |
| Health Care | 3 | 33% |
| Therapeutics | 2 | 22% |
| Medical Device | 2 | 22% |
| Fitness | 1 | 11% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 22% |
| Series C | 2 | 22% |
| Series B | 1 | 11% |
| Series D | 1 | 11% |
| Funding Round | 1 | 11% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 6 | 67% |
| Hong Kong | 1 | 11% |
| United States | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Eluminex Biosciences | Eluminex Biosciences is dedicated to the research and commercialization of novel therapies to address unmet medical needs in the diagnosis, treatment, and control of ocular illnesses. | $40M | Series B | Feb 27, 2023 |  |
| Pulnovo Medical | Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents. |  | Venture - Series Unknown | Nov 07, 2022 |  |
| ENSEM Therapeutics | ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas. | $67M | Series A | Apr 06, 2022 |  |
| Umai Technology | Umai Technology is a skin image management software firm providing image processing, information acquisition, and clinical diagnosis. | $10M | Series A | Nov 05, 2021 |  |
| MagAssist | Suzhou Xinqing Medical Technology Co., Ltd. was founded in 2017 by Dr. Xu Bozhen, a special expert of the National Youth Thousand People Program and a special professor of Suzhou University. He is a high-tech enterprise with the main goal of developing the world's leading in vitro short-term ventricular assist device (in vitro artificialheart). . The core members of the company's entrepreneurial team are the world's top artificial heart engineering technology experts. With years of experience in overseas artificial heart research and development and productization, the company has developed a domestically produced artificial heart with independent intellectual property rights. | $77.8M | Series C | Oct 18, 2021 |  |
| Pulnovo Medical | Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents. | $15.5M | Venture - Series Unknown | Aug 03, 2021 |  |
| VivaVision Biotech | VivaVision Biotech is a clinical-stage R&D biopharmaceutical company. | $46.2M | Series D | Apr 21, 2021 |  |
| Orient Speech Therapy Center | Chinese speech and language therapy operator . | $23M | Series C | Feb 05, 2021 |  |
| Virtus Medical Holdings | Virtus brings together congenial health professionals from a diverse array of healthcare disciplines to provide a full range of healthcare services, from wellness and prevention to treatment and rehabilitation, for people of different ages and at different stages of the health cycle. Virtus’ priority in patient-centred care coordination can be seenthrough the implementation of an integrated medical tower, a custom clinic management system and a health consultant team. | $83M |  | Mar 02, 2018 |  |

9 of 9 investments shown.

## Co-investors
- [Cenova](https://shizune.co/investors/profile/cenova-ventures) — VC Fund, 9 deals together
- [GGV Capital](https://shizune.co/investors/profile/ggv-capital) — VC Fund, 3 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 2 deals together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 2 deals together
- [Lilly Asia Ventures](https://shizune.co/investors/profile/lilly-asia-ventures) — VC Fund, 2 deals together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Cenova Capital invest in?

Cenova Capital invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A and Series C stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cenova Capital last invest?

The most recent investment recorded for Cenova Capital closed in Feb 2023. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co